Stereotaxis (STXS) Research & Development (2010 - 2026)

Stereotaxis (STXS) has reported Research & Development for 17 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Research & Development fell 16.87% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $11.9 million, a 4.83% decrease from a year earlier, with the FY2025 full-year figure at $12.4 million, up 0.57% from the prior year.
• Research & Development was $2.6 million for Q1 2026 at Stereotaxis, down from $3.1 million in the prior quarter.
• Over five years, Research & Development peaked at $3.3 million in Q2 2023 and troughed at $2.6 million in Q1 2026.
• A 5-year average of $3.1 million and a median of $3.1 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development climbed 7.68% in 2022 and slipped 16.87% in 2026, its largest moves.
• Over 5 years, Research & Development stood at $3.0 million in 2022, then decreased by 6.59% to $2.8 million in 2023, then grew by 4.48% to $2.9 million in 2024, then grew by 6.04% to $3.1 million in 2025, then retreated by 15.36% to $2.6 million in 2026.
• The last three Research & Development figures came in at $2.6 million (Q1 2026), $3.1 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.